Using PRP and Cord Blood in Treatment of Covid -19

N/AUnknownNCT04393415

Aljazeera Hospital100 enrolled

Overview

covid - 19 is a critical viral infection that affects humans

Covid -19 pandemic started was declared in 2020

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

100

Conditions

Virus

Interventions

stem cellsCOMBINATION_PRODUCT

giving stem cells to patients with covid - 19

Eligibility

Sex: ALLMin age: 20 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with positive covid -19 and has symptoms and isolated in the hospital Exclusion Criteria: * patients with negative test for covid -19

Locations (1)

Aljazeera( Al Gazeera) hospital

Giza, Egypt

RECRUITING

Outcomes

Primary Outcomes

the number of patients with positive covid 19 who will improve after receiving stem cells

patients with positive covid 19 who will improve after receiving stem cells

Time frame: 2 weeks

Central Contacts

Mahmoud Alalfy, PhD

CONTACT

01002611058 mahmoudalalfy@ymail.com

Mahmoud Alalfy, PhD

CONTACT

0102611058 mahmoudalalfy@ymail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.